Format

Send to

Choose Destination
See comment in PubMed Commons below
Best Pract Res Clin Haematol. 2001 Jun;14(2):365-79.

Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology.

Author information

  • 1Department of Haematology, Haemostasis, Thrombosis Research Centre, Leiden University Medical Centre, P.O. Box 9600, 2300 RC Leiden, The Netherlands.

Abstract

von Willebrand disease type 3 is the most severe form of this condition. Patients present with a moderate-to-severe bleeding tendency. The plasma von Willebrand factor level in these patients is very low or undetectable. Although rare, von Willebrand disease type 3 is of major interest because of its severe clinical presentation, the need for replacement therapy and the risk of occurrence of alloantibodies after the infusion of plasma concentrates. The inheritance of type 3 disease is typically autosomal recessive. The parents are often consanguineous, although compound heterozygous inheritance does occur. The molecular basis of von Willebrand disease type 3 has recently been studied in detail, several molecular defects being identified. This chapter will focus on the clinical and molecular aspects of type 3 von Willebrand disease.

PMID:
11686105
DOI:
10.1053/beha.2001.0139
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center